Hims & Hers $1.2 Billion Global Leap: Can Eucalyptus Cure its GLP-1 Ills? Hims & Hers Health (NYSE:HIMS) just made a bold move to take its personalized wellness platform global. The company announced…
Hims & Hers to acquire Eucalyptus for US$1.15bn Hims & Hers has agreed to buy Eucalyptus in a deal worth up to US$1.15bn, expanding its international digital health…
Hims & Hers: Strategic Eucalyptus Acquisition Accelerates Global Telehealth and Obesity-Care Growth, Supporting Buy Rating Hims & Hers Health, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst David Larsen from…
Hims & Hers HUGE Acquisition News! Hims & Hers is acquiring Eucalyptus and spreading its wings internationally.…
Hims & Hers plans to acquire Eucalyptus for $1.15B The acquisition of the international telehealth company will allow Hims & Hers to expand its presence in Australia, Japan, Germany,…
Hims & Hers eyes international growth with $1.15B Eucalyptus acquisition Consumer health and wellness platform Hims & Hers will ramp up its international presence with the acquisition of Australian digital…
Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B ims & Hers Health, Inc. has entered into an agreement to acquire Eucalyptus, an international digital health company for $1.15…
Hims & Hers Health Stock Resumes Climb on Acquisition News Hims & Hers Health (HIMS) shares are higher today after the company revealed its $1.15 billion acquisition for Australian-based Eucalyptus…
Hims & Hers buys Australian digital health firm for $1.15bn Hims & Hers, facing a threat to its compounded medicines business, has ramped up its push for international expansion by…